方法对比
并排查看您选择的方法；存在差异的行会高亮显示。
| 溃疡性结肠炎的Mayo评分× | Harvey-Bradshaw指数× | |
|---|---|---|
| 领域 | 胃肠病学 | 胃肠病学 |
| 方法族 | Process / pipeline | Process / pipeline |
| 起源年份≠ | 1987 | 1980 |
| 提出者≠ | Schroeder, K. W., Tremaine, W. J., and Ilstrup, D. M. | R. F. Harvey and J. M. Bradshaw |
| 类型 | Clinician-rated | Clinician-rated |
| 开创性文献≠ | Schroeder, K. W., Tremaine, W. J., & Ilstrup, D. M. (1987). Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. New England Journal of Medicine, 317(26), 1625–1629. DOI ↗ | Harvey, R. F., & Bradshaw, J. M. (1980). A simple index of Crohn's-disease activity. Lancet, 315(8167), 514. DOI ↗ |
| 别名≠ | Mayo Clinic Score, UC Mayo Score | HBI |
| 相关≠ | 4 | 5 |
| 摘要≠ | The Mayo Score is a validated tool for assessing disease activity in ulcerative colitis, integrating clinical symptoms and endoscopic findings. Introduced by Schroeder and colleagues in 1987, it has become the reference standard for UC activity assessment in clinical trials and practice. The score combines stool frequency, rectal bleeding, overall physician global assessment, and endoscopic subscore into a single 0–12 scale. | The Harvey-Bradshaw Index (HBI) is a simple, clinician-administered tool for assessing disease activity in Crohn's disease. Developed in 1980, it measures five clinical parameters including abdominal pain, stool frequency, and extraintestinal manifestations. The HBI is widely used in clinical practice and research for monitoring disease progression and treatment response. |
| ScholarGate数据集 ↗ |
|
|